Liminal Financial Statements From 2010 to 2026
Liminal BioSciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Liminal BioSciences' valuation are provided below:Liminal BioSciences does not presently have any fundamental ratios for analysis.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Check Liminal BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Liminal BioSciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Liminal financial statements analysis is a perfect complement when working with Liminal BioSciences Valuation or Volatility modules.
Liminal |
Liminal BioSciences Company Return On Asset Analysis
Liminal BioSciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Liminal BioSciences Return On Asset | -0.39 |
Most of Liminal BioSciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Liminal BioSciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Liminal BioSciences has a Return On Asset of -0.3895. This is 95.55% lower than that of the Biotechnology sector and 98.35% lower than that of the Health Care industry. The return on asset for all United States stocks is 178.21% higher than that of the company.
Liminal BioSciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Liminal BioSciences's current stock value. Our valuation model uses many indicators to compare Liminal BioSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Liminal BioSciences competition to find correlations between indicators driving Liminal BioSciences's intrinsic value. More Info.Liminal BioSciences is rated third overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Liminal BioSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Liminal Stock
If you are still planning to invest in Liminal BioSciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Liminal BioSciences' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |